FDA Says Its Abortion Pill Safety Review Will Continue Into Next Year
The FDA says its safety review of mifepristone will continue into next year, with a final report expected by March 2027. The review was prompted by a court order and is part of an ongoing agency process. No final decisions have been made. A state lawsuit alleges mail delivery undermines abortion bans. Critics have made allegations about the administration's stance, but no official assessment has been issued.
By News Desk ·
